Current Literature References on Clinical Pharmacokinetics
Series 2
Quinine loading dose in cerebral malaria. White, N.J.; Looareesuwan, S.; Warrell, D.A. et al.: American Journal of Tropical Medicine and Hygiene 32: 1 (1983).
Pharmacokinetics of cefotetan in normal subjects and patients with impaired renal function. Ohkawa, M.; Hirano, S.; Tokunaga, S. et al.: Antimicrobial Agents and Chemotherapy 23: 31 (1983).
Ccflriaxone diffusion into cerebrospinal fluid of children with meningitis. Latif, R. and Dajani, A.S.: Antimicrobial Agents and Chemotherapy 23: 46 (1983).
Protein binding of non-steroidal anti-inflammatory drugs in plasma and synovial fluid of arthritic patients. Wanwimolruk, S.; Brooks, P.M. and Birkett, D.J.: British Journal of Clinical Pharmacology 15: 91 (1983).
Plasma binding of thiopentone in late pregnancy. Morgan, D.J.; Toh, C.T.; Blakman, G.L. et al.: British Journal of Clinical Pharmacology 15: 121 (1983).
Diazepam pharmacokinetics after intravenous administration in alcohol withdrawal. Sellers, H.M.; Sandor, P.; Giles, H.G. et al.: British Journal of Clinical Pharmacology 15: 125 (1983).
Scrum chlorpromazine levels in tardive dyskinesia. Rowell, F.J.; Rich, C.G.; Hall, G. et al.: British Journal of Clinical Pharmacology 15: 141P (1983).
Time-course of cis-diamminedichloroplatinum (II) in plasma and urine of ovarian cancer patients. Gill, T.S.; Fish, R.G.; Adams, M. et al.: British Journal of Clinical Pharmacology 15: 145P (1983).
Pharmacokinetic studies of high dose of tiaprofenic acid in patients suffering from arthritis. Daymond, T.J. and Herbert, R.: British Journal of Clinical Pharmacology 15: 157P (1983).
Plasma levels and clinical response with imipramine in a study comparing efficacy with mianserin and nomifensine. Montgomery, S.A.; Roy, D.: Wynne-Wilson, S. et al.: British Journal of Clinical Pharmacology 15(Suppl. 2): 205S (1983).
Alcuronium kinetics in patients undergoing cardiopulmonary bypass surgery. Walker, J.S.; Brown, K.F. and Shanks, C.A.: British Journal of Clinical Pharmacology 15: 237 (1983).
The pharmacokinetics and pharmacodynamics of the diuretic bumetanide in hepatic and renal disease. Marcantonio, L.A.; Auld, W.H.R.; Murdoch, W.R. et al.: British Journal of Clinical Pharmacology 15: 245 (1983).
The pharmacokinelic of mianserin. Shami, M.; Elliott, H.L.; Kelman, A.W. et al.: British Journal of Clinical Pharmacology 15(Suppl. 2): 313S (1983).
Pharmacokinetic observations on dapsone in dermatitis herpetiformis. Swain, A.F.; Ahmad, R.A.; Rogers, H.J. et al.: British Journal of Dermatology 108: 91 (1983).
Hypnotic accumulation and hangover in elderly inpatients: a controlled double-blind study of temazepam and nitrazepam. Cook, P.J.; Huggett, A.; Graham-Pole, R. et al.: British Medical Journal 286: 100 (1983).
Dihydrocodeine narcosis in renal failure. Barnes, J.N. and Goodwin, F.J.: British Medical Journal 286: 438 (1983).
Interactions between mezlocillin and sisomicin in vitro and in patients with normal and various degrees of impaired renal function. Kampf, D.; Schurig, R.; Bergs, A. et al.: Clinical Nephrolosv 19: 37 (1983).
Clinical pharmacokinetics of β-adrenoceptor blocking drugs in thyroid disease. Feely, J.: Clinical Pharmacokinetics 8: 1 (1983).
Clinical pharmacokinetics of systemic antifungal drugs. Daneshmend, T.K. and Warnock, D.W.: Clinical Pharmacokinetics 8: 17 (1983).
Clinical pharmacokinetics of metronidazole. Ralph, E.D.: Clinical Pharmacokinetics 8: 43 (1983).
Reliability of antiarrhythmic drug plasma concentration monitoring. Follath, F.; Ganzinger, U. and Schuetz, E.: Clinical Pharmacokinetics 8: 63 (1983).
Reduced single-dose clearance of clobazam in elderly men predicts increased multiple-dose accumulation. Greenblatt, D.J.; Divoll, M.; Puri, S.K.: et al.: Clinical Pharmacokinetics 8: 83 (1983).
Lorcainide disposition kinetics in arrhythmia patients. Kates, R.E.; Keefc, D.L. and Winkle, R.A.: Clinical Pharmacology and Therapeutics 33: 28 (1983).
Test dose for predicting high-dose methotrexate infusions. Kerr, I.G.; Jolivet, J.; Collins, J.M. et al.: Clinical Pharmacology and Therapeutics 33: 44 (1983).
Ccfazolin and cephalexin kinetics in continuous ambulatory peritoneal dialysis. Bunke, C.M.; Aronoff, G.R.; Brier, M.E. et al.: Clinical Pharmacology and Therapeutics 33: 66 (1983).
Mezlocillin kinetics in hepatic insufficiency. Bunke, C.M.; Aronoff, G.R.; Brier, M.E. et al.: Clinical Pharmacology and Therapeutics 33: 73 (1983).
Acetaminophen in chronic liver disease. Benson, G.D.: Clinical Pharmacology and Therapeutics 33: 95 (1983).
Drugs which can be given to nursing mothers. Drug and Therapeutics Bulletin 21: 5 (1983).
Prediction of maintenance warfarin dosage. Carter, B.L.; Reinders, T.P. and Hamilton, R.A.: Drug Intelligence and Clinical Pharmacy 17: 23 (1983).
Theophylline toxicity — a consequence of congestive heart failure. LeGatt, D.F.: Drug Intelligence and Clinical Pharmacy 17: 59 (1983).
Perspectives on digoxin absorption from small bowel resections. Kumer, K.P.; Nwangwu, J.T. and Nwangwu, P.U.: Drug Intelligence and Clinical Pharmacy 17: 121 (1983).
Computer-assisted drug therapy for epilepsy. Peterson, G.M.: Drug Intelligence and Clinical Pharmacy 17: 123 (1983).
Single-dose ceftriaxone pharmacokinetics in pediatric patients with central nervous system infections. Gould Chadwick, E.; Yogev, R.; Shulman, S.T. et al.: Journal of Clinical Psychiatry 44: 134 (1983).
Blood concentrations of diazepam and its metabolites in children and neonates with tetanus. Tekur, U.; Gupta, A.; Tayal, G. et al.: Journal of Clinical Psychiatry 44: 145 (1983).
Single-dose ceftriaxone pharmacokinetics in pediatrie patients with central nervous system infections. Gould Chadwick, E.; Yogev, R.: Shulman, S.T. et al.: Journal of Pediatrics 102: 134 (1983).
Blood concentrations of diazepam and its metabolites in children and neonates with tetanus. Tekur, U.; Gupta, A.; Tayal, G. et al.: Journal of Pediatrics 102: 145 (1983).
Transplacental passage of doxorubicin. D’Incalci, M.; Broggini, M.; Buscaglia, M. et al.: Lancet 1: 75 (1983).
Phenytoin elimination in newborns. Bourgeois, B.F.D. and Dodson, W.E.: Neurology 33: 173 (1983).
Pharmacokinetics of valproic acid in children: I. Multiple antiepileptic drug therapy. Cloyd, J.C.; Kriel, R.L.; Fischer, J.H. el al.: Neurology 33: 185 (1983).
Plasma ranitidine concentrations after intravenous administration in normal volunteers and haemodialysis patients. Roberts, A.P., Harrison, C.; Dixon, G.T. et al.: Postgraduate Medical Journal 59: 25 (1983).
Series 3
Digoxin kinetics in the elderly. Reid, J.; Kennedy, R.D. and Caird, F.I.: Age and Ageing 12: 29 (1983).
Absolute bioavailability of oral and intramuscular diazepam: Effects of age and sex. Divoll, M.; Greenblatt, D.J.; Ochs, H.R. et al.: Anesthesia and Analgesia 62: 1 (1983).
Plasma binding of pancuronium: Effects of age, sex, and disease. Wood, M; Stone, W.J. and Wood, A.J.J.: Anesthesia and Analgesia 62: 29 (1983).
Concentrations of some antibiotics in synovial fluid after oral administration, with special reference to antistaphylococcal activity. Sattar, M.A.; Barrett, S.P. and Cawley, M.I.D.: Annals of the Rheumatic Diseases 42: 67 (1983).
Pharmacokinetics of sulfadimethoxine in patients with mechanical jaundice and cholangitis. Eeremeishvili, M.G.; Bobrov, V.I.; Beletskaya, G.T.: Antibiotiki 28: 49 (1983).
Ceftazidime levels in human breast milk. Blanco, J.D.; Jorgensen, J.H.; Castaneda, Y.S. et al.: Antimicrobial Agents and Chemotherapy 23: 479 (1983).
Cefoperazone pharmacokinetics in normal subjects and patients with cirrhosis. Boscia, J.A.; Korzeniowski, O.M.; Snepar, R. el al.: Antimicrobial Agents and Chemotherapy 23: 385 (1983).
Cefoperazone pharmacokinetics in preterm infants. Bosso, J.A.; Chan, G.M. and Matsen, J.M.: Antimicrobial Agents and Chemotherapy 23: 413 (1983).
Differences in side effects of amantadine hydrochloride and rimantadine hydrochloride relate to differences in pharmacokinetics. Hayden, F.G.; Hoffman, H.E. and Spyker, D.A.: Antimicrobial Agents and Chemotherapy 23: 458 (1983).
Comparative pharmacokinetics of cefoperazone, cefotaxime, and moxalactam. Kemmerlich, B.; Lode, H.; Belmega, G. et al.: Antimicrobial Agents and Chemotherapy 23: 429 (1983).
Cefsulodin pharmacokinetics in patients with various degrees of renal function. Matzke, G.R. and Keane, W.F.: Antimicrobial Agents and Chemotherapy 23: 369 (1983).
Ceftriaxone pharmacokinetics in newborn infants. McCracken, G.H. Jr: Siegel, J.D.; Threlkeld, N. et al.: Antimicrobial Agents and Chemotherapy 23: 341 (1983).
Comparative concentrations of cefoxitin in human lungs and sera. Perea, E.J.; Garcia-Inglesias, M.C.; Ayarra, J. et al.: Antimicrobial Agents and Chemotherapy 23: 323 (1983).
Single-dose pharmacokinetics of intravenous clavulanic acid with amoxicillin in pediatrie patients. Schaad, U.B.; Casey, P.A. and Cooper, D.L.: Antimicrobial Agents and Chemotherapy 23: 252 (1983).
Pharmacokinetics of ceftriaxone in pediatrie patients with meningitis. Steele, R.W.; Eyre, L.B.; Bradsher, R.W. et al.: Antimicrobial Agents and Chemotherapy 23: 191 (1983).
Pharmacokinetics of cefmenoxine in normal and impaired renal function. Höffler, D. and Koeppe, P.: Arzneimittel-Forschung 33: 269 (1983).
Pharmacokinetics and antiarrhythmic effectiveness of prajmalium bitartrate. Trompler, A.T.; Woodcock, B.G. and Bussmann, W.-D.: Arzneimittel-Forschung 33: 436 (1983).
Pharmacokinetic evaluation of ICI 35 868 in man. Single injection doses with different rates of injection. Adam, H.K.; Briggs, L.P.; Bahar, M. et al.: British Journal of Anaesthesia 55: 97 (1983).
Pharmacokinetics of atracurium besylate in healthy patients (after a single i.v. bolus dose). Ward, S.; Neill, E.A.M.; Weatherley, B.C. el al.: British Journal of Anaesthesia 55: 113 (1983).
The pharmacokinetics and diuretic effects of piretanide in chronic renal insufficiency. Berg, K.J.; Walstad, R.A. and Bergh, K.: British Journal of Clinical Pharmacology 15: 347 (1983).
Dose-response study with ibuprofen in rheumatoid arthritis: Clinical and pharmacokinetic findings. Grennan, D.M.; Aarons, L.; Siddiqui, M. et al.: British Journal of Clinical Pharmacology 15: 311 (1983).
Effect of age and liver cirrhosis on the pharmacokinetics of nitrazepam. Jochemsen, R.; Van Beusekom, B.R.; Spoelstra, P. et al.: British Journal of Clinical Pharmacology 15: 295 (1983).
Characterization of chloroquine plasma protein binding in man. Walker, O.; Birkett, D.J.; Alvan, G. et al.: British Journal of Clinical Pharmacology 15: 375 (1983).
Clinical pharmacokinetics of 5-methyltetrahydro homofolate. Loo, T.L.; Jiushi, K. et al.: Cancer Research 43: 921 (1983).
Elimination kinetics of cefotaxime and desacetyl cefotaxime in patients with renal insufficiency and during hemodialysis. Ohkawa, M.; Okasho, A.; Motoi, I. et al.: Chemotherapy (Basel) 29: 4 (1983).
Clinical pharmacology of clonidine. Frisk-Holmberg, M.: Chest 83(Suppl.): 395 (1983).
Pharmacokinetics and pharmacodynamics of clonidine in varying states of renal function. Lowenthal, D.T.; Affrime, M.B.; Meyer, A. et al.: Chest 83(Suppl.): 386 (1983).
Overview of physiology in senescence. Lowenthal, D.T.; Kim, K.E.; Affrime, M.B. et al.: Chest 83(Suppl.): 408 (1983).
Impairment of lidocaine clearance in elderly male patients. Abernethy, D.R. and Greenblatt, D.J.: Clinical Pharmacology and Therapeutics 33: 202 (1983).
Alprazolam and triazolam: Differential effect of obesity on low vs high-clearance oxidised benzodiazepines. Abernethy, D.R.; Greenblatt, D.J.; Divoll, M. et al.: Clinical Pharmacology and Therapeutics 33: 247 (1983).
Prolonged accumulation of diazepam in obesity. Abernethy, D.R.; Greenblatt, D.J.; Divoll, M. et al.: Clinical Pharmacology and Therapeutics 33: 236 (1983).
Cefmenoxime pharmacokinetics in normal and impaired renal function. Alexander, D.P.; Gambertoglio, J.G.; Barriere, S.L. et al.: Clinical Pharmacology and Therapeutics 33: 234 (1983).
Moxalactam and tobramycin elimination kinetics. Aronoff, G.; Brier, M.: Sloan, R. et al.: Clinical Pharmacology and Therapeutics 33: 248 (1983).
Phenytoin Michaelis-Menten kinetics in Caucasian pediatrics patients. Bauer, L. and Blouin, R.: Clinical Pharmacology and Therapeutics 33: 248 (1983).
Different prednisolone pharmacokinetics in cushingoid and non-cushingoid kidney transplant patients. Bergrem, H.; Jervell, J. and Flatmark, A.: Clinical Pharmacology and Therapeutics 33: 249 (1983).
Pharmacokinetics of ceftizoxime in patients undergoing continuous ambulatory peritoneal dialysis. Blair, A.D. and Burgess, E.D.: Clinical Pharmacology and Therapeutics 33: 249 (1983).
Clinical efficacy and serum concentrations of amiodarone. Boppana, V.K.; Greenspan, A.; Swanson, B.N. et al.: Clinical Pharmacology and Therapeutics 33: 209 (1983).
Pharmacokinetics of vancomycin in continuous ambulatory peritoneal dialysis. Bunke, C.; Aronoff, G.; Brier, M. et al.: Clinical Pharmacology and Therapeutics 33: 263 (1983).
Cimetidine (CMT) pharmacokinetics in critically ill children. Chin, T.W.F.: MacLeod, S.M.; Baltadano, A. et al.: Clinical Pharmacology and Therapeutics 33: 245 (1983).
Comparison of tolmetin kinetics in normals and matched rheumatoid arthritis patients. Furst, D.E.; Dromgoole, S.H.; Fow, S. et al.: Clinical Pharmacology and Therapeutics 33: 267 (1983).
Diminished prednisolone clearance in renal failure. Gambertoglio, J.; Holford, N.; Lizak, P. et al.: Clinical Pharmacology and Therapeutics 33: 264 (1983).
Biotransformation of sulindac in end stage renal disease. Gibson, T.P.; Davies, R.O.; White, L.A. et al.: Clinical Pharmacology and Therapeutics 33: 252 (1983).
Pharmacokinetics of ceftizoxime in pediatrics. Gooch, W.M. III; Swenson, E.; Mutchie, K.D. et al.: Clinical Pharmacology and Therapeutics 33: 235 (1983).
Clinical efficacy of ceftizoxime in management of pediatric infections. Gooch, W.M. III; Mutchie, K.D.; Swenson, E. et al.: Clinical Pharmacology and Therapeutics 33: 234 (1983).
Old age, cimetidine, and disposition of alprazolam and triazolam. Greenblatt, D.J.; Abernethy, D.R.; Divoll, M. et al.: Clinical Pharmacology and Therapeutics 33: 253 (1983).
Altered disposition and availability of cimetidine in patients with liver cirrhosis. Gugler, R.; Muller-Liebenau, B. and Somogyi, A.: Clinical Pharmacology and Therapeutics 33: 217 (1983).
Disopyramide protein binding in normal and uremic serum. Haughey, D.B.; Kraft, C.; Matzke, G.R. et al.: Clinical Pharmacology and Therapeutics 33: 253 (1983).
Pharmacokinetics of hetastarch in patients with renal impairment. Hulse, J.; Gibson, T.P.; Look, Z. et al.: Clinical Pharmacology and Therapeutics 33: 254 (1983).
Bretylium kinetics in renal insufficiency. Josselson, J.; Narang, P.K.; Adir, J. et al.: Clinical Pharmacology and Therapeutics 33: 144 (1983).
Disposition kinetics of lorcainide and norlorcainide in arrhythmia patients. Kates, R.E.; Keefe, D.L.; Yee, Y.G. et ai.: Clinical Pharmacology and Therapeutics 33: 256 (1983).
Plasma levels of cefoperazon after intraperitoneal application. Keller, E.; Jansen, A.; Pelz, K. et al.: Clinical Pharmacology and Therapeutics 33: 235 (1983).
Disposition of intravenous phenytoin in children. Koren, G.; Halkin, H.; Shacher, E. et al.: Clinical Pharmacology and Therapeutics 33: 245 (1983).
Phenyloin CSF levels in children. Koren, G.; Halkin, H.; Shachar, E. et al.: Clinical Pharmacology and Therapeutics 33: 245 (1983).
Lidocaine pharmacokinetics in children with cyanosis. Koska, A.J.; Romagnoli, A. and Kramer, W.G.: Clinical Pharmacology and Therapeutics 33: 208 (1983).
Rights and permissions
About this article
Cite this article
Current Literature References on Clinical Pharmacokinetics. Clin Pharmacokinet 8, 550–552 (1983). https://doi.org/10.2165/00003088-198308060-00007
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003088-198308060-00007